Skip to content
Artemisinin Resistance episode artwork

Oct 5, 2015 6 min

Artemisinin Resistance

from Translational Medicine

Artemisinins are very poweful tools in the treatment of malaria, and the emerging loss of their activity has the potential to create a major public health problem. MALARIA TREATMENT Dr Charlie Woodrow is based at MORU in Bangkok, Thailand, where he coordinates clinical and laboratory studies on resistance to artemisinins. Bringing together diverse datasets of clinical, in vitro and molecular data has helped better understand the emerging resistance, particularly in Myanmar.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Artemisinin Resistance

0:00 6:25

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Translational Medicine?

This episode is 6 minutes long.

When was this Translational Medicine episode published?

This episode was published on October 5, 2015.

Can I download this Translational Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.